FDA Investigator Jin M Kim
Jin M Kim has conducted inspections on 54 sites in 1 countries as of 10 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
54
Last Inspection Date:
10 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Jin M Kim:
Alan P Kurtzberg,
Andrea J Schmidt,
Andrew M Kolenc,
Brandon K Lawson,
Brenda Chavez,
Brent W Higgs,
Brittany R Laymon,
Bruce W Benware,
Bryce A May,
Carla R Hinz,
Carrie E Jolly,
Christina A Mayer,
Christine I Shaw,
Christine L Williams,
Cordelia J Brammer,
Darla J Christopher,
David A Gonzalez,
Debra L Curtis,
Diana L Ayala,
Donald R Hawn,
Duc Minh H Nguyen,
Elisa J Beard,
Elizabeth D Connell,
Elvin R Smith,
Eric R Holm,
Eric S Myskowski,
Erin L Nagel,
Felix J Marrero,
Garrad R Poole,
Gina M Scholze,
Hanna L Potter,
Harry A Wilson,
Holly L Miller,
Isabel Y Espinosa,
James P Stallings,
Jamie L Dion,
Jamie L Port,
Jennifer A Hicks,
Jennifer M Pouget,
John A Daubenspeck,
Joseph M Allen,
Kamara Co,
Kathryn M Mogen,
Keith C Littrell,
Khumo A Phake,
Kimberley A Hoefen,
Kristen E Szenderski,
Lakecha N Lewis,
Larisa E Pavlick,
Larry Gehring,
Laura A Munsterman,
Laura B Kennedy,
Laura L Van Wagenen,
Linda M Cheny,
Manuel A Moreno,
Margo C Jones,
Marie B Buen Bigornia,
Matthew A Kozler,
Matthew R Dionne,
Meaghan M Rabideau,
Merelynn Rhoten,
Michael D Garcia,
Michael R Goga,
Michael S Call,
Michele R Douglas,
Michelle J Hines,
Michelle L Johnson,
Mikayla K Deardorff,
Nathan M Jornod,
Nicholas Fragedakis,
Oluwaseyi Ojinni,
Orval D Mcintire,
Patricia A Maestas,
Paul J Teitell,
Paul Klug,
Paul Z Balcer,
Rebecca S Secrist,
Secrist,
Sheila Alaghemand,
Shererk,
Solomon G Williams,
Steve P Yost,
Tenzin Jangchup,
Vanessa R Muller,
Vincent Thomas,
William A Lanier,
Zachary L Miller
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more